✦ LIBER ✦

Serum Thymidine Kinase 1 Activity in Solid Tumor (Breast and Colorectal Cancer) Patients Treated With Adjuvant Chemotherapy

✍ Scribed by Bolayirli, M.; Papila, C.; Korkmaz, G. G.; Papila, B.; Aydoğan, F.; Karataş, A.; Uzun, H.

Book ID: 120458456
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 594 KB
Volume: 27
Category: Article
ISSN: 0887-8013
DOI: 10.1002/jcla.21587

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1462 POSTER BRCA 1/2 Mutation Carriage i

1462 POSTER BRCA 1/2 Mutation Carriage in Healthy Women and Patients With Breast Cancer is Associated With Elevated Serum Thymidine Kinase 1 Activity

✍ B. Nisman; L. Kaduri; T. Allweis; T. Hamburger; E. Carmon; T. Peretz 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Comparison of diagnostic and prognostic

Comparison of diagnostic and prognostic performance of two assays measuring thymidine kinase 1 activity in serum of breast cancer patients

✍ Nisman, Benjamin; Allweis, Tanir; Kadouri, Luna; Mali, Bela; Hamburger, Tamar; B 📂 Article 📅 2013 🏛 Walter de Gruyter GmbH & Co. KG 🌐 English ⚖ 471 KB

The Role of Serum CEA as a Prognostic In

The Role of Serum CEA as a Prognostic Indicator in Stage II and III Breast Cancer Patients Treated With Adjuvant Chemotherapy

✍ Richard L. Theriault; Gabriel N. Hortobagyi; Herbert A. Fritsche; Debbie Frye; R 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 644 KB

5153 The influence of polymorphism in TY

5153 The influence of polymorphism in TYMS, MTHFR and GSTP1 genes on toxicity and response in breast cancer patients treated with adjuvant chemotherapy

✍ Nowara, E.; Huszno, J.; Butkiewicz, D.; Kalinowska-Herok, M.; Szoltysek, K.; Tec 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

The influence of classical prognostic fa

The influence of classical prognostic factors and adjuvant chemotherapy on disease outcome in early grade 3 node-negative, and 1–3 node-positive breast cancer patients treated with adjuvant cyclophosphamide, methotrexate and fluorouracil (CMF), or untreated patients

✍ S Susnjar; I Kezic; Z Neskovic-Konstantinovic; D Gavrilovic; D Nikolic-Vukosavlj 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Tumor dihydropyrimidine dehydrogenase in

Tumor dihydropyrimidine dehydrogenase in stage II and III colorectal cancer: low level expression is a beneficial marker in oral-adjuvant chemotherapy, but is also a predictor for poor prognosis in patients treated with curative surgery alone

✍ Takashi Tsuji; Terumitsu Sawai; Hiroaki Takeshita; Tohru Nakagoe; Shigekazu Hida 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 130 KB